Does Rallies show 13F holders for ARKG?

Yes. Rallies tracks hedge fund and 13F ownership data for ARKG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ARKG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARKG. It does not provide personalized investment advice.

ARKG (ARK Genomic Revolution) Stock Analysis - Hedge Fund Holdings

ARK Genomic Revolution (ARKG) is a publicly traded Financial Services sector company. As of May 21, 2026, ARKG trades at $29.48 with a market cap of $0 and a P/E ratio of 0.00. ARKG moved +5.25% today. Year to date, ARKG is -1.47%; over the trailing twelve months it is +35.07%. Its 52-week range spans $17.51 to $34.39. Rallies surfaces ARKG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ARKG stock?

Hedge funds tracked by Rallies that own ARKG include Bluecrest Capital. The latest tracked quarter is Jun 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ARK Genomic Revolution.

ARKG Key Metrics

Key financial metrics for ARKG
Metric	Value
Price	$29.48
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.38%
52-Week High	$34.39
52-Week Low	$17.51
Volume	1.64K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding ARKG

Bluecrest Capital holds 46.86K shares of ARKG, changed +0.00% as of Jun 30, 2023.

Latest ARKG News

Mizuho Sets $100 Target on Tempus AI, Shares Jump Over 4% — Feb 19, 2026
ARK Genomic Revolution ETF Up on 3.4% Tempus AI Surge After HRD-RNA Launch — Feb 18, 2026
ARK Genomic Revolution ETF Gains 1% on Personalis Securing Lung Cancer Test Coverage — Feb 10, 2026

ARKG Analyst Consensus

ARKG analyst coverage data. Average price target: $0.00.

Common questions about ARKG

Who owns ARKG stock?: Hedge funds tracked by Rallies that own ARKG include Bluecrest Capital. The latest tracked quarter is Jun 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ARK Genomic Revolution.
Does Rallies show 13F holders for ARKG?: Yes. Rallies tracks hedge fund and 13F ownership data for ARKG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ARKG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARKG. It does not provide personalized investment advice.